American Association of Endocrine Surgeon| Volume 146, ISSUE 6, P1138-1143, December 2009

Neurocognitive dysfunction: A predictor of parathyroid hyperplasia


      To determine whether a symptomatic presentation was associated with parathyroid hyperplasia, we retrospectively examined pre-operative symptom profiles of patients who underwent parathyroidectomy.


      From October 2007 to July 2008, 111 patients with primary hyperparathyroidism completed a preoperative symptom questionnaire prior to parathyroidectomy. The symptom profiles of patients with and without hyperplasia were compared.


      Neurocognitive symptoms occurred in 51.4% of patients. Patients with 1 neurocognitive symptom had a 25% risk of parathyroid hyperplasia. Additional neurocognitive symptoms increased the risk of hyperplasia linearly, with hyperplasia occurring in 38% of patients reporting 2 neurocognitive symptoms (P < .001) and 61% of patients reporting 3 or more of these symptoms (P < .001). A negative sestamibi scan was associated with a 33% risk of hyperplasia. Coupled with at least 1 neurocognitive symptom, the risk of hyperplasia was 53.3% (P < .001). Of patients with 3 or more neurocognitive symptoms and a negative localizing scan, 100% were found to have parathyroid hyperplasia (P < .001).


      The presence of neurocognitive dysfunction in a patient with hyperparathyroidism may be used as a predictor of hyperplastic disease. Three or more of these symptoms, coupled with a negative sestamibi scan, was 100% predictive of parathyroid hyperplasia in our cohort.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Suliburk J.W.
        • Perrier N.D.
        Primary hyperparathyroidism.
        Oncologist. 2007; 12: 644-653
        • Chen H.
        • Mack E.
        • Starling J.R.
        A comprehensive evaluation of perioperative adjuncts during minimally invasive parathyroidectomy: which is most reliable?.
        Ann Surg. 2005; 242: 375-383
        • Lo C.Y.
        • Lang B.H.
        • Chan W.F.
        • Kung A.W.
        • Lam K.S.
        A prospective evaluation of preoperative localization by technetium-99 m sestamibi scintigraphy and ultrasonography in primary hyperparathyroidism.
        Am J Surg. 2007; 193: 155-159
        • Chiu B.
        • Sturgeon C.
        • Angelos P.
        What is the link between nonlocalizing sestamibi scans, multigland disease, and persistent hypercalcemia? A study of 401 consecutive patients undergoing parathyroidectomy.
        Surgery. 2006; 140: 418-422
        • Kebebew E.
        • Hwang J.
        • Reiff E.
        • Duh Q.Y.
        • Clark O.H.
        Predictors of single-gland vs multigland parathyroid disease in primary hyperparathyroidism: A simple and accurate scoring model.
        Arch Surg. 2006; 141 (777,82)
        • Gordon L.
        • Burkhalter W.
        • Mah E.
        Dual-phase 99mTc-sestamibi imaging: its utility in parathyroid hyperplasia and use of immediate/delayed image ratios to improve diagnosis of hyperparathyroidism.
        J Nucl Med Technol. 2002; 30: 179-184
        • Kasai E.T.
        • da Silva J.W.
        Mandarim de Lacerda CA, Boasquevisque E. Parathyroid glands: combination of sestamibi-(99 m)tc scintigraphy and ultrasonography for demonstration of hyperplasic parathyroid glands.
        Rev Esp Med Nucl. 2008; 27: 8-12
        • Lal A.
        • Chen H.
        The negative sestamibi scan: is a minimally invasive parathyroidectomy still possible?.
        Ann Surg Oncol. 2007; 14: 2363-2366
        • Roman S.
        • Sosa J.A.
        Psychiatric and cognitive aspects of primary hyperparathyroidism.
        Curr Opin Oncol. 2007; 19: 1-5
        • Roman S.A.
        • Sosa J.A.
        • Mayes L.
        • Desmond E.
        • Boudourakis L.
        • Lin R.
        • et al.
        Parathyroidectomy improves neurocognitive deficits in patients with primary hyperparathyroidism.
        Surgery. 2005; 138: 1121-1129
        • Mittendorf E.A.
        • Wefel J.S.
        • Meyers C.A.
        • Doherty D.
        • Shapiro S.E.
        • Lee J.E.
        • et al.
        Improvement of sleep disturbance and neurocognitive function after parathyroidectomy in patients with primary hyperparathyroidism.
        Endocr Pract. 2007; 13: 338-344
        • Weber T.
        • Keller M.
        • Hense I.
        • Pietsch A.
        • Hinz U.
        • Schilling T.
        • et al.
        Effect of parathyroidectomy on quality of life and neuropsychological symptoms in primary hyperparathyroidism.
        World J Surg. 2007; 31: 1202-1209
        • Chan R.K.
        • Ruan D.T.
        • Gawande A.A.
        • Moore Jr., F.D.
        Surgery for hyperparathyroidism in image-negative patients.
        Arch Surg. 2008; 143: 335-337
        • Berber E.
        • Parikh R.T.
        • Ballem N.
        • Garner C.N.
        • Milas M.
        • Siperstein A.E.
        Factors contributing to negative parathyroid localization: an analysis of 1000 patients.
        Surgery. 2008; 144: 74-79
        • Dotzenrath C.M.
        • Kaetsch A.K.
        • Pfingsten H.
        • Cupisti K.
        • Weyerbrock N.
        • Vossough A.
        • et al.
        Neuropsychiatric and cognitive changes after surgery for primary hyperparathyroidism.
        World J Surg. 2006; 30: 680-685
        • Weber K.J.
        • Misra S.
        • Lee J.K.
        • Wilhelm S.W.
        • DeCresce R.
        • Prinz R.A.
        Intraoperative PTH monitoring in parathyroid hyperplasia requires stricter criteria for success.
        Surgery. 2004; 136: 1154-1159
        • Ito F.
        • Sippel R.
        • Lederman J.
        • Chen H.
        The utility of intraoperative bilateral internal jugular venous sampling with rapid parathyroid hormone testing.
        Ann Surg. 2007; 245: 959-963
        • Lew J.I.
        • Solorzano C.C.
        • Montano R.E.
        • Carneiro-Pla D.M.
        • Irvin III, G.L.
        Role of intraoperative parathormone monitoring during parathyroidectomy in patients with discordant localization studies.
        Surgery. 2008; 144: 299-306